Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

Neutrophil, lymphocyte and platelet counts, and risk of prostate cancer outcomes in white and black men: results from the SEARCH database.

Vidal AC, Howard LE, de Hoedt A, Cooperberg MR, Kane CJ, Aronson WJ, Terris MK, Amling CL, Taioli E, Fowke JH, Freedland SJ.

Cancer Causes Control. 2018 Jun;29(6):581-588. doi: 10.1007/s10552-018-1031-2. Epub 2018 Apr 17.

PMID:
29663110
2.

Statin use linked with a decrease in the conversion from high-grade prostatic intraepithelial neoplasia (HGPIN) to prostate cancer.

Fowke JH, Motley SS.

Carcinogenesis. 2018 May 28;39(6):819-825. doi: 10.1093/carcin/bgy050.

PMID:
29617729
3.

Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry.

Conti DV, Wang K, Sheng X, Bensen JT, Hazelett DJ, Cook MB, Ingles SA, Kittles RA, Strom SS, Rybicki BA, Nemesure B, Isaacs WB, Stanford JL, Zheng W, Sanderson M, John EM, Park JY, Xu J, Stevens VL, Berndt SI, Huff CD, Wang Z, Yeboah ED, Tettey Y, Biritwum RB, Adjei AA, Tay E, Truelove A, Niwa S, Sellers TA, Yamoah K, Murphy AB, Crawford DC, Gapstur SM, Bush WS, Aldrich MC, Cussenot O, Petrovics G, Cullen J, Neslund-Dudas C, Stern MC, Jarai ZK, Govindasami K, Chokkalingam AP, Hsing AW, Goodman PJ, Hoffmann T, Drake BF, Hu JJ, Clark PE, Van Den Eeden SK, Blanchet P, Fowke JH, Casey G, Hennis AJM, Han Y, Lubwama A, Thompson IM Jr, Leach R, Easton DF, Schumacher F, Van den Berg DJ, Gundell SM, Stram A, Wan P, Xia L, Pooler LC, Mohler JL, Fontham ETH, Smith GJ, Taylor JA, Srivastava S, Eeles RA, Carpten J, Kibel AS, Multigner L, Parent ME, Menegaux F, Cancel-Tassin G, Klein EA, Brureau L, Stram DO, Watya S, Chanock SJ, Witte JS, Blot WJ, Henderson BE, Haiman CA; PRACTICAL/ELLIPSE Consortium.

J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djx084.

4.

Molecular correlates in urine for the obesity and prostatic inflammation of BPH/LUTS patients.

Tyagi P, Motley SS, Koyama T, Kashyap M, Gingrich J, Yoshimura N, Fowke JH.

Prostate. 2018 Jan;78(1):17-24. doi: 10.1002/pros.23439. Epub 2017 Oct 27.

5.

The impact of sociodemographic factors and PSA screening among low-income Black and White men: data from the Southern Community Cohort Study.

Moses KA, Zhao Z, Bi Y, Acquaye J, Holmes A, Blot WJ, Fowke JH.

Prostate Cancer Prostatic Dis. 2017 Dec;20(4):424-429. doi: 10.1038/pcan.2017.32. Epub 2017 Jul 11.

6.

Racial differences in prostate inflammation: results from the REDUCE study.

Vidal AC, Chen Z, Howard LE, Moreira DM, Castro-Santamaria R, Andriole GL, Taioli E, Fowke JH, Knudsen B, Drake CG, Nickel JC, Freedland SJ.

Oncotarget. 2016 Jul 18;8(42):71393-71399. doi: 10.18632/oncotarget.10690. eCollection 2017 Sep 22.

8.

A prospective study of Trichomonas vaginalis and prostate cancer risk among African American men.

Fowke JH, Han X, Alderete JF, Moses KA, Signorello LB, Blot WJ.

BMC Res Notes. 2016 Apr 18;9:224. doi: 10.1186/s13104-016-2033-3.

9.

NF-κB and androgen receptor variant expression correlate with human BPH progression.

Austin DC, Strand DW, Love HL, Franco OE, Jang A, Grabowska MM, Miller NL, Hameed O, Clark PE, Fowke JH, Matusik RJ, Jin RJ, Hayward SW.

Prostate. 2016 Apr;76(5):491-511. doi: 10.1002/pros.23140. Epub 2015 Dec 28.

10.

Two Authors Reply.

Fowke JH, Potter JD.

Am J Epidemiol. 2015 Dec 1;182(11):972. doi: 10.1093/aje/kwv258. Epub 2015 Nov 6. No abstract available.

11.

Associations of body mass index, smoking, and alcohol consumption with prostate cancer mortality in the Asia Cohort Consortium.

Fowke JH, McLerran DF, Gupta PC, He J, Shu XO, Ramadas K, Tsugane S, Inoue M, Tamakoshi A, Koh WP, Nishino Y, Tsuji I, Ozasa K, Yuan JM, Tanaka H, Ahn YO, Chen CJ, Sugawara Y, Yoo KY, Ahsan H, Pan WH, Pednekar M, Gu D, Xiang YB, Sauvaget C, Sawada N, Wang R, Kakizaki M, Tomata Y, Ohishi W, Butler LM, Oze I, Kim DH, You SL, Park SK, Parvez F, Chuang SY, Chen Y, Lee JE, Grant E, Rolland B, Thornquist M, Feng Z, Zheng W, Boffetta P, Sinha R, Kang D, Potter JD.

Am J Epidemiol. 2015 Sep 1;182(5):381-9. doi: 10.1093/aje/kwv089. Epub 2015 Aug 4.

12.

Genetic Determinants of Metabolism and Benign Prostate Enlargement: Associations with Prostate Volume.

Giri A, Edwards TL, Motley SS, Byerly SH, Fowke JH.

PLoS One. 2015 Jul 9;10(7):e0132028. doi: 10.1371/journal.pone.0132028. eCollection 2015.

13.

Physical activity, sedentary behavior and all-cause mortality among blacks and whites with diabetes.

Glenn KR, Slaughter JC, Fowke JH, Buchowski MS, Matthews CE, Signorello LB, Blot WJ, Lipworth L.

Ann Epidemiol. 2015 Sep;25(9):649-55. doi: 10.1016/j.annepidem.2015.04.006. Epub 2015 Jun 9.

14.

Statin use and risk of prostate cancer: Results from the Southern Community Cohort Study.

Kantor ED, Lipworth L, Fowke JH, Giovannucci EL, Mucci LA, Signorello LB.

Prostate. 2015 Sep;75(13):1384-93. doi: 10.1002/pros.23019. Epub 2015 May 27.

15.

Urine chemokines indicate pathogenic association of obesity with BPH/LUTS.

Tyagi P, Motley SS, Kashyap M, Pore S, Gingrich J, Wang Z, Yoshimura N, Fowke JH.

Int Urol Nephrol. 2015 Jul;47(7):1051-8. doi: 10.1007/s11255-015-0992-2. Epub 2015 Apr 30.

16.

Association of cancer susceptibility variants with risk of multiple primary cancers: The population architecture using genomics and epidemiology study.

Park SL, Caberto CP, Lin Y, Goodloe RJ, Dumitrescu L, Love SA, Matise TC, Hindorff LA, Fowke JH, Schumacher FR, Beebe-Dimmer J, Chen C, Hou L, Thomas F, Deelman E, Han Y, Peters U, North KE, Heiss G, Crawford DC, Haiman CA, Wilkens LR, Bush WS, Kooperberg C, Cheng I, Le Marchand L.

Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2568-78. doi: 10.1158/1055-9965.EPI-14-0129. Epub 2014 Aug 19.

17.

Physical activity, sedentary behavior, and cause-specific mortality in black and white adults in the Southern Community Cohort Study.

Matthews CE, Cohen SS, Fowke JH, Han X, Xiao Q, Buchowski MS, Hargreaves MK, Signorello LB, Blot WJ.

Am J Epidemiol. 2014 Aug 15;180(4):394-405. doi: 10.1093/aje/kwu142. Epub 2014 Aug 1.

18.

Vitamin E intake and the lung cancer risk among female nonsmokers: a report from the Shanghai Women's Health Study.

Wu QJ, Xiang YB, Yang G, Li HL, Lan Q, Gao YT, Zheng W, Shu XO, Fowke JH.

Int J Cancer. 2015 Feb 1;136(3):610-7. doi: 10.1002/ijc.29016. Epub 2014 Jun 19.

19.

A functional variant in NKX3.1 associated with prostate cancer risk in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Martinez EE, Darke AK, Tangen CM, Goodman PJ, Fowke JH, Klein EA, Abdulkadir SA.

Cancer Prev Res (Phila). 2014 Sep;7(9):950-7. doi: 10.1158/1940-6207.CAPR-14-0075. Epub 2014 Jun 3.

20.

Pleiotropic associations of risk variants identified for other cancers with lung cancer risk: the PAGE and TRICL consortia.

Park SL, Fesinmeyer MD, Timofeeva M, Caberto CP, Kocarnik JM, Han Y, Love SA, Young A, Dumitrescu L, Lin Y, Goodloe R, Wilkens LR, Hindorff L, Fowke JH, Carty C, Buyske S, Schumacher FR, Butler A, Dilks H, Deelman E, Cote ML, Chen W, Pande M, Christiani DC, Field JK, Bickebller H, Risch A, Heinrich J, Brennan P, Wang Y, Eisen T, Houlston RS, Thun M, Albanes D, Caporaso N, Peters U, North KE, Heiss G, Crawford DC, Bush WS, Haiman CA, Landi MT, Hung RJ, Kooperberg C, Amos CI, Le Marchand L, Cheng I.

J Natl Cancer Inst. 2014 Apr;106(4):dju061. doi: 10.1093/jnci/dju061. Epub 2014 Mar 28.

21.

Alcohol intake increases high-grade prostate cancer risk among men taking dutasteride in the REDUCE trial.

Fowke JH, Howard L, Andriole GL, Freedland SJ.

Eur Urol. 2014 Dec;66(6):1133-8. doi: 10.1016/j.eururo.2014.01.037. Epub 2014 Feb 9.

22.

Surgical intervention for symptomatic benign prostatic hyperplasia is correlated with expression of the AP-1 transcription factor network.

Lin-Tsai O, Clark PE, Miller NL, Fowke JH, Hameed O, Hayward SW, Strand DW.

Prostate. 2014 May;74(6):669-79. doi: 10.1002/pros.22785. Epub 2014 Feb 5.

23.

Validation of a previous day recall for measuring the location and purpose of active and sedentary behaviors compared to direct observation.

Kozey Keadle S, Lyden K, Hickey A, Ray EL, Fowke JH, Freedson PS, Matthews CE.

Int J Behav Nutr Phys Act. 2014 Feb 3;11:12. doi: 10.1186/1479-5868-11-12.

24.

Racial variation in the quality of surgical care for bladder cancer.

Barocas DA, Alvarez J, Koyama T, Anderson CB, Gray DT, Fowke JH, You C, Chang SS, Cookson MS, Smith JA Jr, Penson DF.

Cancer. 2014 Apr 1;120(7):1018-25. doi: 10.1002/cncr.28520. Epub 2013 Dec 11.

25.

Validation of a previous-day recall measure of active and sedentary behaviors.

Matthews CE, Keadle SK, Sampson J, Lyden K, Bowles HR, Moore SC, Libertine A, Freedson PS, Fowke JH.

Med Sci Sports Exerc. 2013 Aug;45(8):1629-38. doi: 10.1249/MSS.0b013e3182897690.

26.

Diabetes and prostate cancer screening in black and white men.

Sanderson M, Fowke JH, Lipworth L, Han X, Ukoli F, Coker AL, Blot WJ, Hargreaves MK.

Cancer Causes Control. 2013 Oct;24(10):1893-9. doi: 10.1007/s10552-013-0257-2. Epub 2013 Jul 17.

27.

Pleiotropy between genetic markers of obesity and risk of prostate cancer.

Edwards TL, Giri A, Motley S, Duong W, Fowke JH.

Cancer Epidemiol Biomarkers Prev. 2013 Sep;22(9):1538-46. doi: 10.1158/1055-9965.EPI-13-0123. Epub 2013 Jun 27.

28.

Genetic risk factors for BMI and obesity in an ethnically diverse population: results from the population architecture using genomics and epidemiology (PAGE) study.

Fesinmeyer MD, North KE, Ritchie MD, Lim U, Franceschini N, Wilkens LR, Gross MD, Bůžková P, Glenn K, Quibrera PM, Fernández-Rhodes L, Li Q, Fowke JH, Li R, Carlson CS, Prentice RL, Kuller LH, Manson JE, Matise TC, Cole SA, Chen CT, Howard BV, Kolonel LN, Henderson BE, Monroe KR, Crawford DC, Hindorff LA, Buyske S, Haiman CA, Le Marchand L, Peters U.

Obesity (Silver Spring). 2013 Apr;21(4):835-46. doi: 10.1002/oby.20268.

29.

Association between race and follow-up diagnostic care after a positive prostate cancer screening test in the prostate, lung, colorectal, and ovarian cancer screening trial.

Barocas DA, Grubb R 3rd, Black A, Penson DF, Fowke JH, Andriole G, Crawford ED.

Cancer. 2013 Jun 15;119(12):2223-9. doi: 10.1002/cncr.28042. Epub 2013 Apr 4.

30.

Effects of smoking on the genetic risk of obesity: the population architecture using genomics and epidemiology study.

Fesinmeyer MD, North KE, Lim U, Bůžková P, Crawford DC, Haessler J, Gross MD, Fowke JH, Goodloe R, Love SA, Graff M, Carlson CS, Kuller LH, Matise TC, Hong CP, Henderson BE, Allen M, Rohde RR, Mayo P, Schnetz-Boutaud N, Monroe KR, Ritchie MD, Prentice RL, Kolonel LN, Manson JE, Pankow J, Hindorff LA, Franceschini N, Wilkens LR, Haiman CA, Le Marchand L, Peters U.

BMC Med Genet. 2013 Jan 11;14:6. doi: 10.1186/1471-2350-14-6.

31.

The influence of obesity-related single nucleotide polymorphisms on BMI across the life course: the PAGE study.

Graff M, Gordon-Larsen P, Lim U, Fowke JH, Love SA, Fesinmeyer M, Wilkens LR, Vertilus S, Ritchie MD, Prentice RL, Pankow J, Monroe K, Manson JE, Le Marchand L, Kuller LH, Kolonel LN, Hong CP, Henderson BE, Haessler J, Gross MD, Goodloe R, Franceschini N, Carlson CS, Buyske S, Bůžková P, Hindorff LA, Matise TC, Crawford DC, Haiman CA, Peters U, North KE.

Diabetes. 2013 May;62(5):1763-7. doi: 10.2337/db12-0863. Epub 2013 Jan 8.

32.

Association between biomarkers of obesity and risk of high-grade prostatic intraepithelial neoplasia and prostate cancer--evidence of effect modification by prostate size.

Fowke JH, Motley S, Dai Q, Concepcion R, Barocas DA.

Cancer Lett. 2013 Jan 28;328(2):345-52. doi: 10.1016/j.canlet.2012.10.010. Epub 2012 Oct 16.

33.

Racial variation in the quality of surgical care for prostate cancer.

Barocas DA, Gray DT, Fowke JH, Mercaldo ND, Blume JD, Chang SS, Cookson MS, Smith JA Jr, Penson DF.

J Urol. 2012 Oct;188(4):1279-85. doi: 10.1016/j.juro.2012.06.037. Epub 2012 Aug 16.

34.

Urinary estrogen metabolites and breast cancer: a combined analysis of individual level data.

Dallal CM, Stone RA, Cauley JA, Ness RB, Vogel VG, Fentiman IS, Fowke JH, Krogh V, Loft S, Meilahn EN, Muti P, Olsen A, Overvad K, Sieri S, Tjønneland A, Ursin G, Wellejus A, Taioli E.

Int J Biol Markers. 2013 Apr 23;28(1):3-16. doi: 10.5301/JBM.2012.9353.

PMID:
22865302
35.

Association between physical activity, lower urinary tract symptoms (LUTS) and prostate volume.

Fowke JH, Phillips S, Koyama T, Byerly S, Concepcion R, Motley SS, Clark PE.

BJU Int. 2013 Jan;111(1):122-8. doi: 10.1111/j.1464-410X.2012.11287.x. Epub 2012 Jun 22.

36.

Differences in the association between serum leptin levels and body mass index in black and white women: a report from the Southern Community Cohort Study.

Cohen SS, Fowke JH, Cai Q, Buchowski MS, Signorello LB, Hargreaves MK, Zheng W, Blot WJ, Matthews CE.

Ann Nutr Metab. 2012;60(2):90-7. doi: 10.1159/000336180. Epub 2012 Feb 18.

37.

Obesity, body composition, and prostate cancer.

Fowke JH, Motley SS, Concepcion RS, Penson DF, Barocas DA.

BMC Cancer. 2012 Jan 18;12:23. doi: 10.1186/1471-2407-12-23.

38.

HTR1B, ADIPOR1, PPARGC1A, and CYP19A1 and obesity in a cohort of Caucasians and African Americans: an evaluation of gene-environment interactions and candidate genes.

Edwards TL, Velez Edwards DR, Villegas R, Cohen SS, Buchowski MS, Fowke JH, Schlundt D, Long J, Cai Q, Zheng W, Shu XO, Hargreaves MK, Smith J, Williams SM, Signorello LB, Blot WJ, Matthews CE.

Am J Epidemiol. 2012 Jan 1;175(1):11-21. doi: 10.1093/aje/kwr272. Epub 2011 Nov 20. Erratum in: Am J Epidemiol. 2012 Apr 1;175(7):732. Long, Ji Rong [corrected to Long, Jirong];Jeffrey, Smith [corrected to Smith, Jeffrey].

39.

Obesity, physical activity and lower urinary tract symptoms: results from the Southern Community Cohort Study.

Penson DF, Munro HM, Signorello LB, Blot WJ, Fowke JH; Urologic Diseases in America Project.

J Urol. 2011 Dec;186(6):2316-22. doi: 10.1016/j.juro.2011.07.067. Epub 2011 Oct 20.

40.

Evaluation of a questionnaire to assess sedentary and active behaviors in the Southern Community Cohort Study.

Buchowski MS, Matthews CE, Cohen SS, Signorello LB, Fowke JH, Hargreaves MK, Schlundt DG, Blot WJ.

J Phys Act Health. 2012 Aug;9(6):765-75. Epub 2011 Aug 2.

41.

Association between socioeconomic status (SES) and lower urinary tract symptom (LUTS) severity among black and white men.

Fowke JH, Munro H, Signorello LB, Blot WJ, Penson DF; Urologic Diseases of America Project.

J Gen Intern Med. 2011 Nov;26(11):1305-10. doi: 10.1007/s11606-011-1776-8. Epub 2011 Jul 1.

42.

Blood magnesium, and the interaction with calcium, on the risk of high-grade prostate cancer.

Dai Q, Motley SS, Smith JA Jr, Concepcion R, Barocas D, Byerly S, Fowke JH.

PLoS One. 2011 Apr 25;6(4):e18237. doi: 10.1371/journal.pone.0018237.

43.

Oxidative stress measured by urine F2-isoprostane level is associated with prostate cancer.

Barocas DA, Motley S, Cookson MS, Chang SS, Penson DF, Dai Q, Milne G, Roberts LJ 2nd, Morrow J, Concepcion RS, Smith JA Jr, Fowke JH.

J Urol. 2011 Jun;185(6):2102-7. doi: 10.1016/j.juro.2011.02.020. Epub 2011 Apr 15.

44.

Helicobacter pylori prevalence and circulating micronutrient levels in a low-income United States population.

Epplein M, Signorello LB, Zheng W, Cai Q, Hargreaves MK, Michel A, Pawlita M, Fowke JH, Correa P, Blot WJ.

Cancer Prev Res (Phila). 2011 Jun;4(6):871-8. doi: 10.1158/1940-6207.CAPR-10-0398. Epub 2011 Mar 24.

45.

The associations between statin use and prostate cancer screening, prostate size, high-grade prostatic intraepithelial neoplasia (PIN), and prostate cancer.

Fowke JH, Motley SS, Barocas DA, Cookson MS, Concepcion R, Byerly S, Smith JA Jr.

Cancer Causes Control. 2011 Mar;22(3):417-26. doi: 10.1007/s10552-010-9713-4. Epub 2010 Dec 19.

46.

Urinary isothiocyanate levels and lung cancer risk among non-smoking women: a prospective investigation.

Fowke JH, Gao YT, Chow WH, Cai Q, Shu XO, Li HL, Ji BT, Rothman N, Yang G, Chung FL, Zheng W.

Lung Cancer. 2011 Jul;73(1):18-24. doi: 10.1016/j.lungcan.2010.10.024. Epub 2010 Nov 30.

47.

Serum adiponectin in relation to body mass index and other correlates in black and white women.

Cohen SS, Gammon MD, Signorello LB, North KE, Lange EM, Fowke JH, Hargreaves MK, Cai Q, Zheng W, Blot WJ, Matthews CE.

Ann Epidemiol. 2011 Feb;21(2):86-94. doi: 10.1016/j.annepidem.2010.10.011. Epub 2010 Dec 15.

48.

Multiple physician recommendations for prostate cancer treatment: a Pandora's box for patients?

Underwood W 3rd, Orom H, Poch M, West BT, Lantz PM, Chang SS, Fowke JH.

Can J Urol. 2010 Oct;17(5):5346-54.

PMID:
20974025
49.

Smaller prostate size predicts high grade prostate cancer at final pathology.

Newton MR, Phillips S, Chang SS, Clark PE, Cookson MS, Davis R, Fowke JH, Herrell SD, Baumgartner R, Chan R, Mishra V, Blume JD, Smith JA Jr, Barocas DA.

J Urol. 2010 Sep;184(3):930-7. doi: 10.1016/j.juro.2010.04.082.

PMID:
20643423
50.

The association of plasma fatty acids with prostate cancer risk in African Americans and Africans.

Ukoli FA, Fowke JH, Akumabor P, Oguike T, Taher KA, Murff HJ, Amaefuna ER, Kittles R, Ahaghotu C, Osime U, Beech DJ.

J Health Care Poor Underserved. 2010 Feb;21(1 Suppl):127-47. doi: 10.1353/hpu.0.0242.

PMID:
20173289

Supplemental Content

Loading ...
Support Center